178 related articles for article (PubMed ID: 27940597)
21. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
22. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
23. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
[TBL] [Abstract][Full Text] [Related]
24. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.
Kuwana M; Fujii T; Mimori T; Kaburaki J
Arthritis Rheum; 1996 Apr; 39(4):686-91. PubMed ID: 8630122
[TBL] [Abstract][Full Text] [Related]
26. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.
Whyte J; Earnshaw WC; Champoux JJ; Parker LH; Stewart L; Hall ND; McHugh NJ
Clin Exp Immunol; 1995 May; 100(2):214-8. PubMed ID: 7743657
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.
Sato S; Hamaguchi Y; Hasegawa M; Takehara K
Rheumatology (Oxford); 2001 Oct; 40(10):1135-40. PubMed ID: 11600743
[TBL] [Abstract][Full Text] [Related]
28. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
[TBL] [Abstract][Full Text] [Related]
29. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
30. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
31. Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis.
Kuwana M; Kaburaki J; Mimori T; Tojo T; Homma M
Arthritis Rheum; 1993 Oct; 36(10):1406-13. PubMed ID: 7692859
[TBL] [Abstract][Full Text] [Related]
32. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1995 Sep; 155(5):2703-14. PubMed ID: 7650398
[TBL] [Abstract][Full Text] [Related]
33. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
Mahler M; Silverman ED; Schulte-Pelkum J; Fritzler MJ
Autoimmun Rev; 2010 Sep; 9(11):756-60. PubMed ID: 20601198
[TBL] [Abstract][Full Text] [Related]
34. Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.
Homer KL; Warren J; Karayev D; Khanna PP; Young A; Nagaraja V; Metzger AL; Khanna D
J Clin Rheumatol; 2020 Apr; 26(3):115-118. PubMed ID: 30585996
[TBL] [Abstract][Full Text] [Related]
35. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.
Hanke K; Dähnrich C; Brückner CS; Huscher D; Becker M; Jansen A; Meyer W; Egerer K; Hiepe F; Burmester GR; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R28. PubMed ID: 19232127
[TBL] [Abstract][Full Text] [Related]
37. Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis.
Meesters TM; Hoet M; van den Hoogen FH; Verheijen R; Habets WJ; van Venrooij WJ
Mol Biol Rep; 1992 May; 16(2):117-23. PubMed ID: 1318998
[TBL] [Abstract][Full Text] [Related]
38. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
39. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.
McHugh NJ; Whyte J; Harvey G; Haustein UF
Arthritis Rheum; 1994 Aug; 37(8):1198-205. PubMed ID: 8053959
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
Seelig HP; Schröter H; Ehrfeld H; Renz M
J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]